We are live on ! Find out more
TWD

True Wealth Design Portfolio holdings

AUM $420M
1-Year Est. Return 22.7%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+22.7%
3 Year Est. Return
+52.99%
5 Year Est. Return
10 Year Est. Return
AUM
$327M
AUM Growth
+$43.4M
Cap. Flow
+$28.6M
Cap. Flow %
8.75%
Top 10 Hldgs %
74.02%
Holding
2,918
New
354
Increased
1,322
Reduced
446
Closed
207

Sector Composition

Rank Sector Weight
1 Miscellaneous 83.97%
2 Technology 4.05%
3 Industrials 2.58%
4 Financials 2.02%
5 Consumer Discretionary 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPCE icon
2826
Neuropace
NPCE
$495M
-10
Closed -$112
NTIC icon
2827
Northern Technologies International Corp
NTIC
$77.2M
-1
Closed -$8
NVEE
2828
DELISTED
NV5 Global
NVEE
-11
Closed -$254
NWN icon
2829
Northwest Natural Holdings
NWN
$2.08B
-17
Closed -$676
NX icon
2830
Quanex
NX
$892M
-49
Closed -$927
OCGN icon
2831
Ocugen
OCGN
$448M
-244
Closed -$237
OLO
2832
DELISTED
Olo Inc
OLO
-90
Closed -$801
OLP
2833
One Liberty Properties
OLP
$529M
-4
Closed -$96
ACH
2834
Accendra Health
ACH
$93.1M
-552
Closed -$5.02K
ONEW icon
2835
OneWater Marine
ONEW
$199M
-1
Closed -$14
OPAD icon
2836
Offerpad Solutions
OPAD
$21.3M
-4
Closed -$34
OSUR icon
2837
OraSure Technologies
OSUR
$248M
-22
Closed -$66
OTLK icon
2838
Outlook Therapeutics
OTLK
$156M
-20
Closed -$32
OVID icon
2839
Ovid Therapeutics
OVID
$547M
-8
Closed -$3
PCVX icon
2840
Vaxcyte
PCVX
$8.9B
-34
Closed -$1.11K
PLL
2841
DELISTED
Piedmont Lithium
PLL
-11
Closed -$65
PLRX icon
2842
Pliant Therapeutics
PLRX
$68.7M
-19
Closed -$23
PLSE icon
2843
Pulse Biosciences
PLSE
$3.39B
-2
Closed -$31
PPBI
2844
DELISTED
Pacific Premier Bancorp
PPBI
-816
Closed -$17.2K
PRLD icon
2845
Prelude Therapeutics
PRLD
$437M
-13
Closed -$11
PROK icon
2846
ProKidney
PROK
$382M
-11
Closed -$7
PRPL icon
2847
Purple Innovation
PRPL
$18.6M
-4
Closed -$74
PUBM icon
2848
PubMatic
PUBM
$766M
-28
Closed -$349
PUMP icon
2849
ProPetro Holding
PUMP
$1.35B
-36
Closed -$215
PYXS icon
2850
Pyxis Oncology
PYXS
$269M
-276
Closed -$304

Similar funds

True Wealth Design's Q3 2025 Portfolio in Review

As of Q3 2025, True Wealth Design held 2,918 positions worth $327M, up 15% from $284M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

True Wealth Design deployed $28.6M of net new capital in Q3 2025, opening 354 new positions and adding to 1,322 existing holdings. Its largest new stake was HSBC: 780 shares worth $55.4K.

By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 89% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Avantis US Equity ETF, an estimated $269K trimmed.

  • True Wealth Design's largest Q3 2025 buy was HSBC: 780 shares worth $55.4K.
  • True Wealth Design added most to Alpha Architect 1-3 Month Box ETF in Q3 2025, an estimated $9.97M increase.
  • True Wealth Design's biggest Q3 2025 reduction was Avantis US Equity ETF, cutting an estimated $269K.
  • True Wealth Design fully exited Schwab International Equity ETF in Q3 2025, selling an estimated $80.2K.
  • True Wealth Design's ten largest holdings make up 74% of its $327M portfolio in Q3 2025.
  • True Wealth Design opened 354 new positions and closed 207 in Q3 2025.
  • True Wealth Design's portfolio value rose 15% quarter-over-quarter to $327M.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.